How big is the 3D Bioprinting Market?

The 3D Bioprinting Market size is expected to reach USD 1.44 billion in 2024 and grow at a CAGR of 15.89% to reach USD 3 billion by 2029. Read More

What is the current 3D Bioprinting Market size?

In 2024, the 3D Bioprinting Market size is expected to reach USD 1.44 billion. Read More

Who are the key players in 3D Bioprinting Market?

Cellink, 3D Systems Corporation, 3D Bioprinting Solutions, REGEMAT 3D and Aspect Biosystems Ltd are the major companies operating in the 3D Bioprinting Market. Read More

Which is the fastest growing region in 3D Bioprinting Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in 3D Bioprinting Market?

In 2024, the North America accounts for the largest market share in 3D Bioprinting Market. Read More

What years does this 3D Bioprinting Market cover, and what was the market size in 2023?

In 2023, the 3D Bioprinting Market size was estimated at USD 1.21 billion. The report covers the 3D Bioprinting Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the 3D Bioprinting Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key regulatory hurdles for companies entering the 3D Bioprinting Market?

The key regulatory hurdles for companies entering the 3D Bioprinting Market are a) Biomaterial safety standards b) Tissue viability requirements c) Navigating regulatory approval processes Read More

What are the ethical considerations surrounding the use of 3D Bioprinting Technology?

The ethical considerations surrounding the use of 3D Bioprinting Technology are a) Informed consent for bioprinting procedures b) Potential misuse of the technology Read More

What are the key regulatory hurdles for companies entering the 3D Bioprinting Market?

The key regulatory hurdles for companies entering the 3D Bioprinting Market are a) Biomaterial safety standards b) Tissue viability requirements c) Navigating regulatory approval processes Read More

3D Bioprinting Market Report | Industry Analysis, Size & Forecast Insights

3D Bioprinting Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global 3D Bioprinting Market Report is Segmented by Technology (Syringe/Extrusion Bioprinting, Inkjet Bioprinting, Magnetic Levitation Bioprinting, and Laser-Assisted Bioprinting), Component (3D Bioprinters, Biomaterials, and Scaffolds), Application (Drug Testing and Development, Regenerative Medicine, Food Testing, and Research), and Geography.

3D Bioprinting Industry Overview

The 3D bioprinting market is very competitive in nature. The market is concentrated due to the presence of various small and large players. Some of the significant players in the market are 3D Systems Corporation, Aspect Biosystems Ltd, GeSIM GmbH, Cellink AB, Cyfuse Biomedical KK, and Envision TEC GmbH.

May 2024: Nanoscribe and Advanced BioMatrix collaborated to lead the way in the field of bioprinting by introducing four cutting-edge bioresins designed specifically for Two-Photon Polymerization (2PP) based 3D printing. This partnership brings together Nanoscribe's extensive knowledge in highly accurate 3D printing and Advanced BioMatrix's expertise in developing biomaterials, with the goal of greatly improving bioprinting capabilities. These groundbreaking bioresins offer unparalleled precision, resolution, and adaptability, opening up new avenues for exploration and advancement in the life sciences and biomedical sectors and ultimately contributing to the progress of human health.
September 2023: CELLINK entered into a strategic distribution agreement with Paralab, which signified a notable growth in its operations in Portugal and Spain. This partnership was expected to enable CELLINK to reach a wider audience in Southern Europe by offering advanced bioprinting solutions. By doing so, the company reaffirmed its dedication to advancing regenerative medicine while taking into account the specific characteristics of the region. The collaboration will prioritize the exchange of knowledge, training, and technical support, ensuring that researchers in Portugal and Spain can effectively utilize CELLINK's state-of-the-art bioprinting platforms.